retatrutide weight loss clinical trial results Phase 3: TRIUMPH Program 2026 Phase III retatrutide study demonstrates

It remains an investigational medicine available only through clinical trials

Retatrutide Efficacy: The Phase 2 obesity trial, published in the New England Journal of Medicine (NEJM) , provided the most impressive initial results

Eur Neuropsychopharmacol

Muscle mass and glucagon-like peptide-1 receptor agonists: Adaptive or maladaptive response to weight loss

Empowered Wellness Begins With GLP-1 Therapy for Sustainable Weight Management and Metabolic Health Trusted since 2009 MD & RN Supervised Responsive & Caring Staff Struggling with Stubborn Weight, Cravings, or Plateaus GLP-1 treatments offer a medically guided solution to support appetite control, improve metabolic function, and promote long-term weight losshelping you achieve your health goals with clarity and confidence GLP-1 Weight Management Therapy Experience a science-backed approach to sustainable weight loss with GLP-1 medications, such as semaglutide and tirzepatide

A: The evidence is mixed